Pharmacology of ginsenosides: a literature review

Chinese Medicine

Volumn 5, Issue , 2010, Pages

  Leung, Kar W ^a   Wong, Alice S ^b  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENOSIDE; STEROID RECEPTOR;

BIOAVAILABILITY; BIODEGRADATION; DRUG STRUCTURE; GINSENG; IMMUNOMODULATION; MEDICINAL PLANT; NONHUMAN; PARTIAL AGONISM; REVIEW;

EID: 77953307436     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-5-20     Document Type: Review

References (103)

1. Eliason BC, Kruger J, Mark D, Rasmann DN. Dietary supplement users: demographics, product use and medical system interaction. J Am Board Fam Pract 1997, 10:265-271.
2. Harnack LJ, Rydell SA, Stang J. Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, Metropolitan area. Mayo Clin Proc 2001, 76:688-694. 10.4065/76.7.688, 11444400.
3. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992, 36:27-38. 10.1016/0378-8741(92)90057-X, 1501490.
4. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999, 58:1685-1693. 10.1016/S0006-2952(99)00212-9, 10571242.
5. Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 2006, 11:128-150.
6. Xiang YZ, Shang HC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother Res 2008, 22:851-858. 10.1002/ptr.2384, 18567057.
7. Shibata S, Fujita M, Itokawa H, Tanako O, Ishii T. Studies on the constituents of Japanese and Chinese Crude Drugs. XI. Panaxadiol, a sapogenin of ginseng roots. (1). Chem Pharm Bull (Tokyo) 1963, 11:759-761.
8. Shibata S, Tanaka O, Soma K, Ando T, Iida Y, Nakamura H. Studies on saponins and sapogenins of ginseng. The structure of panaxatriol. Tetrahedron Lett 1965, 42:207-213. 10.1016/S0040-4039(01)99595-4, 14252492.
9. Matsuura H, Kasai R, Tanaka O, Saruwatari Y, Kunihiro K, Fuwa T. Further studies on the dammarane-saponins of ginseng roots. Chem Pharm Bull (Tokyo) 1984, 32:1188-1192.
10. De Smet PAGM. Herbal remedies. N Engl J Med 2002, 347:2046-2056. 10.1056/NEJMra020398, 12490687.
11. Namba T, Matsushige K, Morita T, Tanaka O. Saponins of plants of Panax species collected in central Nepal and their chemotaxonomical significance. Chem Pharm Bull (Tokyo) 1986, 34:730-738.
12. Sanada S, Kondo N, Shoji J, Tanaka O, Shibata S. Studies on the saponin of ginseng. I. Structures of ginsenoside-Ro, -Rb1, -Rc, and -Rd. Chem Pharm Bull (Tokyo) 1974, 22:421-428.
13. Lim W, Mudge KW, Vermeylen F. Effects of population, age, and cultivation methods on ginsenoside content of wild American ginseng (Panax quinquefolium). J Agric Food Chem 2005, 53:8498-8505. 10.1021/jf051070y, 16248544.
14. Schlag EM, Mclntosh MS. Ginsenoside content and variation among and within American ginseng (Panax quinquefolius L.) populations. Phytochemistry 2006, 67:1510-1519. 10.1016/j.phytochem.2006.05.028, 16839573.
15. Li W, Gu C, Zhang H, Awang DVC, Fitzloff JF, Fong HHS, van Breemen RB. Use of high-performance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C.A. meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). Anal Chem 2000, 72:5417-5422. 10.1021/ac000650l, 11080895.
16. Assinewe VA, Baum BR, Gagnon D, Arnason JT. Phytochemistry of wild populations of Panax quinquefolium L. (North American ginseng). J Agric Food Chem 2003, 51:4549-4553. 10.1021/jf030042h, 14705875.
17. Soldati F, Tanaka O. Panax ginseng: relation between age of plant and content of ginsenosides. Planta Med 1984, 50:351-352. 10.1055/s-2007-969729, 17340326.
18. Court WA, Reynolds LB, Hendel JG. Influence of root age on the concentration of ginsenosides of American ginseng (Panax quinquefolium). Can J Plant Sci 1996, 76:853-855.
19. Kaneko H, Nakanishi K. Proof of the mysterious efficacy of ginseng: basic effects of medical ginseng, Korean red ginseng: its anti-stress action for prevention of disease. J Pharmacol Sci 2004, 95:158-162. 10.1254/jphs.FMJ04001X5, 15215639.
20. Kasai R, Besso H, Tanaka O, Saruwatari Y, Fuwa T. Saponins of red ginseng. Chem Pharm Bull (Tokyo) 1983, 31:2120-2125.
21. Kim SI, Park JH, Ryu JH, Park JD, Lee YH, Park JH, Kim TH, Baek NI. Ginsenoside Rg5, a genuine dammarane glycoside from Korean red ginseng. Arch Pharm Res 1996, 19:551-553.
22. Ryu JH, Park JH, Eun JH, Jung JH, Sohn DH. A dammarane glycoside from Korean red ginseng. Phytochemistry 1997, 44:931-933.
23. Park JD, Lee YH, Kim SI. Ginsenoside Rf2, a new dammarane glycoside from Korean red ginseng (Panax ginseng). Arch Pharm Res 1998, 21:615-617. 10.1007/BF02975384, 9875504.
24. Kwon SW, Han SB, Park IH, Kim JM, Park MK, Park JH. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J Chromatogr A 2001, 921:335-339. 10.1016/S0021-9673(01)00869-X, 11471818.
25. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000, 63:1702-1704. 10.1021/np990152b, 11141123.
26. Lee KY, Lee YH, Kim SI, Park JH, Lee SK. Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21Cip/WAF1 and down-regulating cyclin E in SK-HEP-1 cells. Anticancer Res 1997, 17:1067-1072.
27. Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 2000, 67:1297-1306. 10.1016/S0024-3205(00)00720-7, 10972198.
28. Xu TM, Xin Y, Cui MH, Jiang X, Gu LP. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chinese Med J (Engl) 2007, 120:584-588.
29. Kim YJ, Kwon HC, Ko H, Park JH, Kim HY, Yoo JH, Yang HO. Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biol Pharm Bull 2008, 31:826-830. 10.1248/bpb.31.826, 18451501.
30. Yoo JH, Kwon HC, Kim YJ, Park JH, Yang HO. KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice. Cancer Lett 2010, 289:99-110. 10.1016/j.canlet.2009.08.008, 19765891.
31. Park SA, Kim EH, Na HK, Surh YJ. KG-135 inhibits COX-2 expression by blocking the activation of JNK and AP-1 in phorbol ester-stimulated human breast epithelial cells. Ann N Y Acad Sci 2007, 1095:545-553. 10.1196/annals.1397.059, 17404068.
32. Cutler SJ, Cutler HG. Biologically Active Natural Products: Pharmaceuticals. 2000, New York: CRC Press.
33. Hall T, Lu ZZ, Yat PN, Fitzloff JF, Arnason JT, Awang DVC, Fong HHS, Blumenthal M. Evaluation of consistency of standardized Asian ginseng products in the ginseng evaluation program. HerbalGram 2001, 52:31-45.
34. Chang TKH, Chen J, Benetton SA. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2 and CYP1B1. Drug Metab Dispos 2002, 30:378-384. 10.1124/dmd.30.4.378, 11901090.
35. Casanova H, Ortiz C, Peláez C, Vallejo A, Moreno ME, Acevedo M. Insecticide formulations based on nicotine oleate stabilized by sodium caseinate. J Agric Food Chem 2002, 50:6389-6394. 10.1021/jf0257244, 12381122.
36. Fukami H, Nakajima M. Rotenone and rotenoids. Naturally Occurring Insecticides 1971, 71. New York: Marcel Dekker, Jacobson M, Crosby DG.
37. Elliott M. Properties and applications of pyrethroids. Environ Health Perspect 1976, 14:1-13. 10.2307/3428357, 1475105, 789056.
38. Aerts RJ, Mordue AJ. Feeding deterrence and toxicity of neem triterpenoids. J Chem Ecol 1997, 23:2117-2132.
39. Creelman RA, Mullet JE. Biosynthesis and action of jasmonates in plants. Annu Rev Plant Physiol Plant Mol Biol 1997, 48:355-381. 10.1146/annurev.arplant.48.1.355, 15012267.
40. Palazon J, Cusido RM, Bonfill M, Mallol A, Moyano E, Morales C, Pinol MT. Elicitation of different Panax ginseng transformed root phenotypes for an improved ginsenoside production. Plant Physiol Biochem 2003, 41:1019-1025.
41. Choi DW, Jung JD, Ha YI, Park HW, In DS, Chung HJ, Liu JR. Analysis of transcripts in methyl jasmonate-treated ginseng hairy roots to identify genes involved in the biosynthesis of ginsenosides and other secondary metabolites. Plant Cell Rep 2005, 23:557-566. 10.1007/s00299-004-0845-4, 15538577.
42. Nicol RW, Traquair JA, Bernards MA. Ginsenosides as host resistance factors in American ginseng (Panax quinquefolius). Can J Bot 2002, 80:557-562.
43. Katerere DR, Gray AI, Nash RJ, Waigh RD. Antimicrobial activity of pentacyclic triterpenes isolated from African Combretaceae. Phytochemistry 2003, 63:81-88. 10.1016/S0031-9422(02)00726-4, 12657301.
44. Mallvadhani UV, Mahapatra A, Raja SS, Manjula C. Antifeedant activity of some pentacyclic triterpene acids and their fatty acid ester analogues. J Agric Food Chem 2003, 51:1952-1955. 10.1021/jf020691d, 12643657.
45. Bernards MA, Yousef LF, Nicol RW. The allelopathic potential of ginsenosides. Allelochemicals: Biological Control of Plant Pathogens and Diseases 2006, 157-175. Netherlands: Springer, Inderjit, Mukerji KG.
46. Sung WS, Lee DG. In vitro candidacidal action of Korean red ginseng saponins against candida albicans. Biol Pharm Bull 2008, 31:139-143. 10.1248/bpb.31.139, 18175957.
47. Ferro N, Tacoronte JE, Reinard T, Bultinck P, Montero LA. Structure-activity analysis on ecdysteroids: a structure and quantum chemical approach based on two biological systems. J Mol Struct: THEOCHEM 2005, 758:263-274.
48. Harada T, Nakagawa Y, Akamatsu M, Miyagawa H. Evaluation of hydrogen bonds of ecdysteroids in the ligand-receptor interactions using a protein modeling system. Bioorg Med Chem 2009, 17:5868-5873. 10.1016/j.bmc.2009.07.011, 19631551.
49. Rudakewich M, Ba F, Benishin CG. Neurotrophic and neuroprotective actions of ginsenosides Rb1 and Rg1. Planta Med 2001, 67:533-537. 10.1055/s-2001-16488, 11509974.
50. Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F, Zhou YC, Zhao CH. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol 2003, 473:1-7. 10.1016/S0014-2999(03)01945-9, 12877931.
51. Hwang YP, Jeong HG. Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol 2010, 242:18-28. 10.1016/j.taap.2009.09.009, 19781563.
52. Ge KL, Chen WF, Xie JX, Wong MS. Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways. J Ethnopharmacol 2010, 127:118-123. 10.1016/j.jep.2009.09.038, 19799986.
53. Zhu JR, Tao YF, Lou S, Wu ZM. Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells. Acta Pharmacol Sin 2010, 31:273-280. 10.1038/aps.2010.9, 20140005.
54. Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ, Yuan CS. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006, 532:201-207. 10.1016/j.ejphar.2006.01.001, 16497296.
55. Xie XS, Liu HC, Yang M, Zuo C, Deng Y, Fan JM. Ginsenoside Rb1, a panoxadiol saponin against oxidative damage and renal interstitial fibrosis in rats with unilateral ureteral obstruction. Chin J Integr Med 2009, 15:133-140. 10.1007/s11655-009-0133-9, 19407952.
56. Zhu D, Wu L, Li CR, Wang XW, Ma YJ, Zhong ZY, Zhao HB, Cui J, Xun SF, Huang XL, Zhou Z, Wang SQ. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem 2009, 108:117-124. 10.1002/jcb.22233, 19530220.
57. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RNS, Sasisekharan R, Fan TPD. Modulating angiogenesis: The Yin and the Yang in ginseng. Circulation 2004, 110:1219-1225. 10.1161/01.CIR.0000140676.88412.CF, 15337705.
58. Leung KW, Pon YL, Wong RNS, Wong AST. Ginsenoside-Rg1 induces vascular endothelial growth factor expression through glucocorticoid receptor-related phosphatidylinositol 3-kinse/Akt and β-catenin/TCF-dependent pathway in human endothelial cells. J Biol Chem 2006, 281:36280-36288. 10.1074/jbc.M606698200, 17008323.
59. Leung KW, Cheung LWT, Pon YL, Wong RNS, Mak NK, Fan TPD, Au SCL, Tombran-Tink J, Wong AST. Ginsenoside-Rb1 inhibits angiogenesis by regulating pigment epithelium-derived factor through the beta estrogen receptor. Br J Pharmacol 2007, 152:207-215. 10.1038/sj.bjp.0707359, 1978254, 17603552.
60. Yang ZG, Sun HX, Ye YP. Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis. Chem Biodivers 2006, 3:187-197. 10.1002/cbdv.200690022, 17193257.
61. Kitts DD, Popovich DG, Hu C. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells. Can J Physiol Pharmacol 2007, 85:1173-1183. 10.1139/Y07-099, 18066119.
62. Lei J, Li X, Gong XJ, Zheng YN. Isolation, synthesis and structures of cytotoxic ginsenoside derivatives. Molecules 2007, 12:2140-2150. 10.3390/12092140, 17962732.
63. Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002, 406:1-8. 10.1016/S0003-9861(02)00398-3, 12234484.
64. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 2004, 27:61-67. 10.1007/BF02980048, 14969341.
65. Liu Y, Zhang JW, Li W, Ma H, Sun J, Deng MC, Yang L. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol Sci 2006, 91:356-364. 10.1093/toxsci/kfj164, 16547074.
66. Sankawa U, Sung CK, Han BH, Akiyama T, Kawashima K. Radioimmunoassay for the determination of ginseng saponin, ginsenoside Rg1. Chem Pharm Bull (Tokyo) 1982, 30:1907-1910.
67. Tanaka H, Fukuda N, Shoyama Y. Formation of monoclonal antibody against a major ginseng component, ginsenoside Rb1 and its characterization. Cytotechnology 1999, 29:115-120.
68. Fukuda N, Tanaka H, Shoyama Y. Formation of monoclonal antibody against a major ginseng component, ginsenoside Rg1 and its characterization. Chytotechnology 2000, 34:197-204.
69. Morinaga O, Tanaka H, Shoyama Y. Detection and quantification of ginsenoside Re in ginseng samples by chromatographic immunostaining method using monoclonal antibody against ginsenoside Re. J Chromatogr B 2006, 830:100-104.
70. Joo EJ, Ha YW, Shin H, Son SH, Kim YS. Generation and characterization of monoclonal antibody to ginsenoside Rg3. Biol Pharm Bull 2009, 32:548-552. 10.1248/bpb.32.548, 19336882.
71. Karikura M, Miyase T, Tanizawa H, Takino Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VI. The decomposition products of ginsenoside Rb2 in the stomach of rats. Chem Pharm Bull (Tokyo) 1991, 39:400-404.
72. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1996, 62:453-457. 10.1055/s-2006-957938, 8923812.
73. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside Re by human intestinal bacteria and its related antiollergic activity. Biol Pharm Bull 2002, 25:743-747. 10.1248/bpb.25.743, 12081140.
74. Hasegawa H, Sung JH, Benno Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med 1997, 63:436-440. 10.1055/s-2006-957729, 9342949.
75. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 1998, 50:1155-1160.
76. Chi H, Kim DH, Ji GE. Transformation of ginsenoside Rb2 and Rc from Panax ginseng by food microorganisms. Biol Pharm Bull 2005, 28:2102-2105. 10.1248/bpb.28.2102, 16272697.
77. Xie HT, Wang GJ, Chen M, Jiang XL, Li H, Lv H, Huang CR, Wang R, Roberts M. Uptake and metabolism of ginsenoside Rh2 and its aglycon protopanaxadiol by Caco-2 cells. Biol Pharm Bull 2005, 28:383-386. 10.1248/bpb.28.383, 15684507.
78. Han M, Fang XL. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models. Acta Pharmacol Sin 2006, 27:499-505. 10.1111/j.1745-7254.2006.00303.x, 16539852.
79. Han M, Sha X, Wu Y, Fang X. Oral absorption of ginsenoside Rb1 using in vitro and in vivo models. Planta Med 2006, 72:398-404. 10.1055/s-2005-916211, 16557452.
80. Xiong J, Sun M, Guo J, Huang L, Wang S, Meng B, Ping Q. Active absorption of ginsenoside Rg1 in vitro and in vivo: the role of sodium-dependent glucose co-transporter 1. J Pharm Pharmacol 2009, 61:381-386. 10.1211/jpp/61.03.0014, 19222912.
81. Karikura M, Miyase T, Tanizawa H, Takino Y, Taniyama T, Hayashi T. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Chem Pharm Bull (Tokyo) 1990, 38:2859-2861.
82. Takino Y. Studies on pharmacodynamics of ginsenoside-Rg1, Rb1 and -Rb2 in rats. Yakugaku Zasshi 1994, 114:550-564.
83. Xu QF, Fand XL, Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmcol 2003, 84:187-192.
84. Odani T, Tanizawa H, Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chem Pharm Bull (Tokyo) 1983, 31:292-298.
85. Odani T, Tanizawa H, Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. III. The absorption, distribution and excretion of ginsenoside Rb1 in the rat. Chem Pharm Bull (Tokyo) 1983, 31:1059-1066.
86. Xiong J, Sun M, Guo J, Huang L, Wang S, Meng B, Ping Q. Enhancement by adrenaline of ginsenoside Rg1 transport in Caco-2 cells and oral absorption in rats. J Pharm Pharmacol 2009, 61:347-352. 10.1211/jpp/61.03.0009, 19222907.
87. Xiong J, Guo J, Huang L, Meng B, Ping Q. The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats. Drug Dev Ind Pharm 2008, 34:65-72. 10.1080/03639040701508292, 18214757.
88. Han M, Fu S, Gao JQ, Fang XL. Evaluation of intestinal absorption of ginsenoside Rg1 incorporated in microemulison using parallel artificial membrane permeability assay. Biol Pharm Bull 2009, 32:1069-1074. 10.1248/bpb.32.1069, 19483317.
89. Kim SW, Kwon HY, Chi DW, Shim JH, Park JD, Lee YH, Pyo S, Rhee DK. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochem Pharmacol 2003, 65:75-82. 10.1016/S0006-2952(02)01446-6, 12473381.
90. Kwon HY, Kim EH, Kim SW, Kim SN, Park JD, Rhee DK. Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation. Arch Pharm Res 2008, 31:171-177. 10.1007/s12272-001-1137-y, 18365686.
91. Salim KN, McEwen BS, Chao HM. Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. Mol Brain Res 1997, 47:177-182. 10.1016/S0169-328X(97)00042-9, 9221915.
92. Choi S, Lee JH, Oh S, Rhim H, Lee SM, Nah SY. Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes. Mol Cells 15:108-113.
93. Kim HS, Hwang SL, Oh S. Ginsenoside Rc and Rg1 differentially modulate NMDA receptor subunit mRNA levels after intracerebroventricular infusion in rats. Neurochem Res 2000, 25:1149-1154. 10.1023/A:1007634432095, 11055754.
94. Choi S, Jung SY, Lee JH, Sala F, Criado M, Mulet J, Valor LM, Sala S, Engel AG, Nah SY. Effects of ginsenosides, active components of ginseng, on nicotinic acetylcholine receptors expressed in Xenopus oocytes. Eur J Pharmacol 2002, 442:37-45. 10.1016/S0014-2999(02)01508-X, 12020680.
95. Lee YJ, Chung E, Lee KY, Lee YH, Huh B, Lee SK. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrinol 1997, 133:135-140. 10.1016/S0303-7207(97)00160-3, 9406859.
96. Leung KW, Cheng YK, Mak NK, Chan KKC, Fan TPD, Wong RNS. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 2006, 580:3211-3216. 10.1016/j.febslet.2006.04.080, 16696977.
97. Leung KW, Leung FP, Huang Y, Mak NK, Wong RNS. Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Lett 2007, 581:2423-2428. 10.1016/j.febslet.2007.04.055, 17490654.
98. Lee YJ, Jin YR, Lim WC, Ji SM, Choi S, Jang S, Lee SK. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol 2003, 84:463-468. 10.1016/S0960-0760(03)00067-0, 12732291.
99. Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 2002, 9:145-150. 10.1097/00042192-200203000-00010, 11875334.
100. Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KPL, Booth N, Constantinou AI, Pezzuto JM, Fong HHS, Farnsworth NR, Bolton JL. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001, 49:2472-2479. 10.1021/jf0014157, 11368622.
101. Gao QG, Chen WF, Xie JX, Wong MS. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. J Neurochem 2009, 109:1338-1347. 10.1111/j.1471-4159.2009.06051.x, 19476546.
102. Furukawa T, Bai CX, Kaihara A, Ozaki E, Kawano T, Nakaya Y, Awais M, Sato M, Umezawa Y, Kurokawa J. Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones. Mol Pharmacol 2006, 70:1916-1924. 10.1124/mol.106.028134, 16985185.
103. Leung KW, Leung FP, Mak NK, Tombran-Tink J, Huang Y, Wong RNS. Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells. Br J Pharmacol 2009, 156:626-637. 10.1111/j.1476-5381.2008.00066.x, 2697710, 19226254.